Re-Innovation in Clinical Trial Designs Based on Precision TherapyOA
Re-Innovation in Clinical Trial Designs Based on Precision Therapy
Shenglan Li;Jiachen Wang;Zhuang Kang;Xun Kang;Feng Chen;Wenbin Li
Department of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,ChinaDepartment of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,ChinaDepartment of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,ChinaDepartment of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,ChinaDepartment of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,ChinaDepartment of Neuro-Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,China
adaptive trialsbiomarkersclinical trialsprecision medicine
adaptive trialsbiomarkersclinical trialsprecision medicine
《肿瘤学创新（英文）》 2025 (5)
84-91,8
This study was funded by Talent Introduction Fund of Beijing Tiantan Hospital(RCYJ-2020-2025-LWB),the Beijing Clinical Key Specialty Project(2-1-2-038),National Natural Science Foundation(32471036)and National Natural Science Foundation Youth Fund(82303822).
评论